Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

1.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

827
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
827
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.1K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.1K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

16
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
16
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

8.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolated Protein C Deficiency in a Newborn.

Clinical laboratory·2023
Same author

Xeroderma pigmentosum and acute myeloid leukemia: a case report.

Journal of medical case reports·2021
Same author

Acquired Hemophilia A: Three Cases and Review of the Literature.

Clinical laboratory·2019
Same author

Congenital factor II deficiency: moroccan cases.

International journal of laboratory hematology·2012
Same author

Reactive hemophagocytic syndrome caused by Rickettsial infection: report of a case.

Laboratory hematology : official publication of the International Society for Laboratory Hematology·2012
Same journal

Profilin-1 as a Potential Biomarker in Acute Ischemic Stroke: Predictive Value for Large Vessel Occlusion and Mechanical Thrombectomy.

Clinical laboratory·2026
Same journal

Soluble Thrombomodulin can Predict In-Hospital Mortality of Community-Acquired Pneumonia Patients in Intensive Care Unit.

Clinical laboratory·2026
Same journal

Cytomegalovirus Seroprevalence in Morocco - a 10-Year Single-Center Study.

Clinical laboratory·2026
Same journal

Impact of Inactivated SARS-CoV-2 Vaccines on Serum Glycan Profiles and Protein N-Glycosylation.

Clinical laboratory·2026
Same journal

Albumin Concentration Associates Linearly with Unfavorable Outcomes at Three Months Post-Acute Ischemic Stroke in Koreans.

Clinical laboratory·2026
Same journal

Prognostic Value of the Blood Urea Nitrogen-to-Albumin Ratio for ICU Mortality in Cardiogenic Shock Patients: Evidence from the MIMIC-IV Database.

Clinical laboratory·2026
See all related articles

Related Experiment Video

Updated: Aug 16, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.0K

Acquired and Isolated Deficiencies in Factor VII.

F Z Alouhmy, H Bencharef, S Oufaska

    Clinical Laboratory
    |December 22, 2022
    PubMed
    Summary
    This summary is machine-generated.

    Acquired factor VII deficiency is rare, often linked to sepsis or cancer. This study details two such cases, highlighting the importance of inhibitor screening in specific clinical contexts.

    More Related Videos

    Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
    12:24

    Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes

    Published on: June 3, 2014

    12.4K
    Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
    08:13

    Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

    Published on: September 30, 2021

    6.4K

    Related Experiment Videos

    Last Updated: Aug 16, 2025

    Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
    13:08

    Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

    Published on: September 9, 2012

    19.0K
    Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
    12:24

    Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes

    Published on: June 3, 2014

    12.4K
    Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
    08:13

    Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

    Published on: September 30, 2021

    6.4K

    Area of Science:

    • Hematology
    • Coagulation Disorders

    Background:

    • Acquired factor VII deficiency is exceptionally rare.
    • Previously reported cases are associated with severe sepsis or neoplastic pathologies.
    • These deficiencies are typically caused by proteases or inhibitors.

    Observation:

    • This report details two distinct cases of acquired, isolated factor VII deficiency.
    • Both cases involved the presence of factor VII inhibitors.
    • The first patient's deficiency was linked to bacterial sepsis; the second to squamous cell carcinoma.

    Findings:

    • The study identified inhibitors against factor VII as the cause of deficiency in both patients.
    • The underlying conditions were bacterial sepsis and squamous cell carcinoma, respectively.
    • Diagnosis was confirmed in the Hematology Laboratory of CHU Ibn Rochd.

    Implications:

    • Factor VII deficiency can be acquired, not just constitutional.
    • Screening for anti-factor VII antibodies is crucial in patients presenting with unexplained factor VII deficiency.
    • Diluted thromboplastin time testing should be considered based on clinical suspicion.